27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.
Thomas E. Timbie, insider at Treace Medical Concepts

Thomas E. Timbie Insider Information

Thomas E. Timbie has served as a member of our board of directors since June 2014 and served as our Chief Financial Officer from July 2014 to October 2015. Mr. Timbie is the President of Timbie & Company, LLC, a financial and management consulting firm he founded in 2000. Mr. Timbie has over 30 years of financial experience primarily in the medical device market. During 2005, as the interim Chief Financial Officer of ev3 Inc., acquired by Covidien in 2010 and now part of Medtronic plc. (NYSE: MDT), Mr. Timbie helped lead ev3 through their initial public offering. He was also the Chief Financial Officer of Xomed Surgical Products, Inc., including during its initial public offering in 1996, and continuing in that role until Xomed was acquired by Medtronic plc (NYSE: MDT) in 1999. Prior to Xomed, Mr. Timbie was the Chief Financial Officer of TreBay Medical Corp., a private orthopaedic and microsurgical device company, and the Director of Accounting at Concept Inc., a leader in the arthroscopy device market, now known as Conmed Linvatec (NYSE: CNMD). Timbie has also previously served as a member of the board of directors of Wright Medical Group, Inc., acquired by Stryker Corporation (NYSE: SYK) in November 2020; ev3 Inc., until its acquisition by Covidien (part of Medtronic plc. (NYSE: MDT)); and American Medical Systems, Inc., now part of Endo Pharmaceuticals (NASDAQ: ENDP). Mr. Timbie holds a B.S. in Accounting from University of Florida, an M.B.A. from Stetson University and is a certified public accountant (current status inactive). Mr. Timbie has also served as a board member and audit committee chairman of several public and private medical device companies including Wright Medical, Inc. acquired by Stryker Corporation (NYSE: SYK) in November 2020; ev3 Inc., acquired by Covidien in 2010 and now part of Medtronic plc. (NYSE: MDT); Acclarent, Inc., acquired by Johnson & Johnson (NYSE: JNJ) in 2010; and American Medical Systems, Inc. acquired by Endo Pharmaceuticals (NASDAQ: ENDP) in 2011. Mr. Timbie is also a former board member and audit committee chairman of two health care services companies, LaVie Care Centers and RegionalCare Hospital Partners.

What is Thomas E. Timbie's net worth?

The estimated net worth of Thomas E. Timbie is at least $29.17 million as of August 5th, 2022. Mr. Timbie owns 1,499,069 shares of Treace Medical Concepts stock worth more than $29,171,883 as of August 11th. This net worth estimate does not reflect any other assets that Mr. Timbie may own. Additionally, Mr. Timbie receives a salary of $39,120.00 as Director at Treace Medical Concepts. Learn More about Thomas E. Timbie's net worth.

How old is Thomas E. Timbie?

Mr. Timbie is currently 64 years old. There are 8 older executives and no younger executives at Treace Medical Concepts. Learn More on Thomas E. Timbie's age.

What is Thomas E. Timbie's salary?

As the Director of Treace Medical Concepts, Inc., Mr. Timbie earns $39,120.00 per year. There are 3 executives that earn more than Mr. Timbie. The highest earning executive at Treace Medical Concepts is Mr. Mark L. Hair CPA, Chief Financial Officer, who commands a salary of $688,220.00 per year. Learn More on Thomas E. Timbie's salary.

How do I contact Thomas E. Timbie?

The corporate mailing address for Mr. Timbie and other Treace Medical Concepts executives is 203 FORT WADE RD. SUITE 150, PONTE VEDRA FL, 32081. Treace Medical Concepts can also be reached via phone at 904-373-5940 and via email at [email protected] Learn More on Thomas E. Timbie's contact information.

Has Thomas E. Timbie been buying or selling shares of Treace Medical Concepts?

Over the course of the past ninety days, Thomas E. Timbie has sold $1,919,541.31 of Treace Medical Concepts stock. Most recently, Thomas E. Timbie sold 4,904 shares of the business's stock in a transaction on Friday, August 5th. The shares were sold at an average price of $19.04, for a transaction totalling $93,372.16. Following the completion of the sale, the director now directly owns 1,499,069 shares of the company's stock, valued at $28,542,273.76. Learn More on Thomas E. Timbie's trading history.

Who are Treace Medical Concepts' active insiders?

Treace Medical Concepts' insider roster includes Sean Scanlan (SVP), Thomas Timbie (Director), James Treace (Director), John Treace (CEO), and John Treace (Director). Learn More on Treace Medical Concepts' active insiders.

Are insiders buying or selling shares of Treace Medical Concepts?

During the last twelve months, Treace Medical Concepts insiders bought shares 2 times. They purchased a total of 8,700 shares worth more than $144,510.00. During the last twelve months, insiders at the sold shares 37 times. They sold a total of 894,234 shares worth more than $16,202,225.43. The most recent insider tranaction occured on August, 5th when Director Thomas E Timbie sold 4,904 shares worth more than $93,372.16. Insiders at Treace Medical Concepts own 41.9 % of the company. Learn More about insider trades at Treace Medical Concepts.

Information on this page was last updated on 8/5/2022.

Thomas E. Timbie Insider Trading History at Treace Medical Concepts

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/5/2022Sell4,904$19.04$93,372.161,499,069View SEC Filing Icon  
8/3/2022Sell96,879$18.85$1,826,169.151,552,190View SEC Filing Icon  
10/20/2021Sell11,171$25.18$281,285.78View SEC Filing Icon  
See Full Table

Thomas E. Timbie Buying and Selling Activity at Treace Medical Concepts

This chart shows Thomas E Timbie's buying and selling at Treace Medical Concepts by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Treace Medical Concepts Company Overview

Treace Medical Concepts logo
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
Read More

Today's Range

Now: $19.48
Low: $19.41
High: $19.76

50 Day Range

MA: $16.16
Low: $13.59
High: $19.71

2 Week Range

Now: $19.48
Low: $12.48
High: $31.02

Volume

1,234 shs

Average Volume

153,572 shs

Market Capitalization

$1.08 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.06
Biden & Bill Gates Igniting $40 Trillion Heist?
Has President Biden’s new executive order…

Alongside MIT, 77 global Governments, The Gates Foundation, UNICEF, and The Clinton Development Initiative…

Ignited a historic $40 trillion transfer of wealth from the middle class, to the rich?
Uncover exactly what’s happening here